MOUNTAIN LAKE ACQUISITION-A (MLAC) Fundamental Analysis & Valuation

NASDAQ:MLAC • KYG6301B1014

Current stock price

10.53 USD
0 (0%)
At close:
10.53 USD
0 (0%)
After Hours:

This MLAC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MLAC Profitability Analysis

1.1 Basic Checks

  • In the past year MLAC was profitable.
  • In the past year MLAC has reported a negative cash flow from operations.
  • Of the past 5 years MLAC 4 years were profitable.
  • MLAC had a negative operating cash flow in each of the past 5 years.
MLAC Yearly Net Income VS EBIT VS OCF VS FCFMLAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 2M 4M 6M 8M

1.2 Ratios

Industry RankSector Rank
ROA 3.43%
ROE 3.44%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MLAC Yearly ROA, ROE, ROICMLAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60 -80

1.3 Margins

  • MLAC does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
MLAC Yearly Profit, Operating, Gross MarginsMLAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. MLAC Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for MLAC remains at a similar level compared to 1 year ago.
  • The number of shares outstanding for MLAC has been increased compared to 5 years ago.
  • There is no outstanding debt for MLAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MLAC Yearly Shares OutstandingMLAC Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2024 2025 10M 20M 30M
MLAC Yearly Total Debt VS Total AssetsMLAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 151.51 indicates that MLAC is not in any danger for bankruptcy at the moment.
  • There is no outstanding debt for MLAC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 151.51
ROIC/WACCN/A
WACCN/A
MLAC Yearly LT Debt VS Equity VS FCFMLAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2024 2025 0 50M 100M 150M 200M

2.3 Liquidity

  • A Current Ratio of 1.91 indicates that MLAC should not have too much problems paying its short term obligations.
  • MLAC has a Quick Ratio of 1.91. This is a normal value and indicates that MLAC is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.91
MLAC Yearly Current Assets VS Current LiabilitesMLAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2024 2025 1M 2M 3M 4M 5M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. MLAC Growth Analysis

3.1 Past

  • MLAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 412.86%, which is quite impressive.
  • The earnings per share for MLAC have been decreasing by -12.31% on average. This is quite bad
EPS 1Y (TTM)412.86%
EPS 3Y-12.31%
EPS 5YN/A
EPS Q2Q%8.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. MLAC Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 39.00, MLAC can be considered very expensive at the moment.
  • The average S&P500 Price/Earnings ratio is at 24.89. MLAC is valued rather expensively when compared to this.
Industry RankSector Rank
PE 39
Fwd PE N/A
MLAC Price Earnings VS Forward Price EarningsMLAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MLAC Per share dataMLAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MLAC Dividend Analysis

5.1 Amount

  • No dividends for MLAC!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MLAC Fundamentals: All Metrics, Ratios and Statistics

MOUNTAIN LAKE ACQUISITION-A

NASDAQ:MLAC (3/27/2026, 8:00:01 PM)

After market: 10.53 0 (0%)

10.53

0 (0%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)02-20
Earnings (Next)05-11
Inst Owners99.68%
Inst Owner Change51825.9%
Ins OwnersN/A
Ins Owner Change0%
Market Cap326.32M
Revenue(TTM)N/A
Net Income(TTM)8.28M
Analysts0
Price TargetN/A
Short Float %0.45%
Short Ratio1.22
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 39
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.36
P/tB 1.36
EV/EBITDA N/A
EPS(TTM)0.27
EY2.56%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS0
BVpS7.76
TBVpS7.76
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.87
Profitability
Industry RankSector Rank
ROA 3.43%
ROE 3.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.91
Quick Ratio 1.91
Altman-Z 151.51
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)412.86%
EPS 3Y-12.31%
EPS 5YN/A
EPS Q2Q%8.71%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2473.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-482.05%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-482.05%
OCF growth 3YN/A
OCF growth 5YN/A

MOUNTAIN LAKE ACQUISITION-A / MLAC Fundamental Analysis FAQ

What is the fundamental rating for MLAC stock?

ChartMill assigns a fundamental rating of 2 / 10 to MLAC.


What is the valuation status for MLAC stock?

ChartMill assigns a valuation rating of 0 / 10 to MOUNTAIN LAKE ACQUISITION-A (MLAC). This can be considered as Overvalued.


Can you provide the profitability details for MOUNTAIN LAKE ACQUISITION-A?

MOUNTAIN LAKE ACQUISITION-A (MLAC) has a profitability rating of 1 / 10.


Can you provide the financial health for MLAC stock?

The financial health rating of MOUNTAIN LAKE ACQUISITION-A (MLAC) is 6 / 10.